Aging is related to gradual increase of interleukin 6 (IL-6) plasma level that affects peroxisome proliferator-activated receptor (PPAR) expression. We evaluated age-related changes in cardiac expression of PPARα, its coactivator PGC-1α, and selected downstream proteins in mice with systemic IL-6 knockout (IL6KO). Male C57BL6/J wild-type (WT) and IL6KO mice were used at the age of 16–20 weeks (young) and 24–30 months (senescent). Echocardiography and electron microscopy were applied to assess the function and ultrastructure of the heart. Western blotting and quantitative real-time PCR were used to estimate protein and mRNA levels of selected genes. PPARα expression in the myocardium of young IL6KO animals is lower and remains unchanged with aging, whereas in WT mice it declines with age and in both senescent groups it is equal. We observed aging-related upregulation of PGC-1α and less pronounced decline of Sirt3 in IL6KO animals; the level of cytochrome C was significantly decreased in IL6KO group only, suggesting disturbed mitochondrial function, which was not sufficient to evoke obvious changes in cardiac performance and function assessed by echocardiography. IL-6 and aging are involved in regulation of PPARα and PGC-1α expression and may influence the mitochondrial function.
Get full access to this article
View all access options for this article.
References
1.
AdriaensenW, MatheiC, VaesB, van PottelberghG, WallemacqP, DegryseJM. 2015. Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study. Exp Gerontol, 69:53–61.
2.
AkbaralyTN, HamerM, FerrieJE, LoweG, BattyGD, Hagger-JohnsonG, Singh-ManouxA, ShipleyMJ, KivimakiM. 2013. Chronic inflammation as a determinant of future aging phenotypes. CMAJ, 185(16):E763–E770.
3.
BachD, NaonD, PichS, SorianoFX, VegaN, RieussetJ, LavilleM, GuilletC, BoirieY, Wallberg-HenrikssonH, MancoM, CalvaniM, CastagnetoM, PalacinM, MingroneG, ZierathJR, VidalH, ZorzanoA. 2005. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes, 54(9):2685–2693.
4.
BondaTA, SzynakaB, SokolowskaM, DziemidowiczM, WaszkiewiczE, WinnickaMM, BernaczykP, Wawrusiewicz-KurylonekN, KaminskiKA. 2016a. Interleukin 6 modulates PPARalpha and PGC-1alpha and is involved in high-fat diet induced cardiac lipotoxicity in mouse. Int J Cardiol, 219:1–8.
5.
BondaTA, SzynakaB, SokolowskaM, DziemidowiczM, WinnickaMM, ChyczewskiL, KaminskiKA. 2016b. Remodeling of the intercalated disc related to aging in the mouse heart. J Cardiol, 68(3):261–268.
6.
BondaTA, TarantaA, KaminskiKA, DziemidowiczM, LitvinovichS, KozuchM, BialukI, ChyczewskiL, WinnickaMM. 2013. CCN1 expression in interleukin-6 deficient mouse kidney in experimental model of heart failure. Folia Histochem Cytobiol, 51(1):84–91.
7.
CarrollCJ, SayanBS, BaileySG, McCormickJ, StephanouA, LatchmanDS, TownsendPA. 2013. Regulation of myocardial interleukin-6 expression by p53 and STAT1. J Interferon Cytokine Res, 33(9):542–548.
8.
CencioniC, SpallottaF, MaiA, MartelliF, FarsettiA, ZeiherAM, GaetanoC. 2015. Sirtuin function in aging heart and vessels. J Mol Cell Cardiol, 83:55–61.
9.
ChabowskiA, ZmijewskaM, GorskiJ, BonenA, KaminskiK, WinnickaMM. 2007. Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits. J Physiol Pharmacol, 58(1):73–82.
HafnerAV, DaiJ, GomesAP, XiaoCY, PalmeiraCM, RosenzweigA, SinclairDA. 2010. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY), 2(12):914–923.
15.
HanL, LiM, LiuY, HanC, YeP. 2012. Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats. Pharmacology, 89(1–2):74–82.
16.
HudzikB, SzkodzinskiJ, RomanowskiW, DanikiewiczA, WilczekK, LekstonA, PolonskiL, Zubelewicz-SzkodzinskaB. 2011. Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease. Cytokine, 54(3):266–271.
17.
IemitsuM, MiyauchiT, MaedaS, TanabeT, TakanashiM, Irukayama-TomobeY, SakaiS, OhmoriH, MatsudaM, YamaguchiI. 2002. Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. Am J Physiol Heart Circ Physiol, 283(5):H1750–H1760.
18.
JasiewiczM, KnappM, WaszkiewiczE, Ptaszynska-KopczynskaK, SzpakowiczA, SobkowiczB, MusialWJ, KaminskiKA. 2015. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Cytokine, 76(2):187–192.
19.
KalogeropoulosA, GeorgiopoulouV, PsatyBM, RodondiN, SmithAL, HarrisonDG, LiuY, HoffmannU, BauerDC, NewmanAB, KritchevskySB, HarrisTB, ButlerJ, HealthABCSI. 2010. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol, 55(19):2129–2137.
20.
KaminskiKA, KozuchM, BondaTA, StepaniukMM, WaszkiewiczE, ChyczewskiL, MusialWJ, WinnickaMM. 2009a. Effect of interleukin 6 deficiency on the expression of Bcl-2 and Bax in the murine heart. Pharmacol Rep, 61(3):504–513.
21.
KaminskiKA, SzepietowskaB, BondaT, KozuchM, MencelJ, MalkowskiA, SobolewskiK, KovalchukO, ChyczewskiL, SzelachowskaM, GorskaM, MusialWJ, WinnickaMM. 2009b. CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice. Pharmacol Rep, 61(3):496–503.
22.
KincaidB, Bossy-WetzelE. 2013. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci, 5:48.
LiL, MuhlfeldC, NiemannB, PanR, LiR, Hilfiker-KleinerD, ChenY, RohrbachS. 2011. Mitochondrial biogenesis and PGC-1alpha deacetylation by chronic treadmill exercise: differential response in cardiac and skeletal muscle. Basic Res Cardiol, 106(6):1221–1234.
25.
Lopez-OtinC, BlascoMA, PartridgeL, SerranoM, KroemerG. 2013. The hallmarks of aging. Cell, 153(6):1194–1217.
26.
O'TooleJF, PatelHV, NaplesCJ, FujiokaH, HoppelCL. 2010. Decreased cytochrome c mediates an age-related decline of oxidative phosphorylation in rat kidney mitochondria. Biochem J, 427(1):105–112.
27.
ParmentierJH, SchohnH, BronnerM, FerrariL, BattAM, DaucaM, KremersP. 1997. Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1beta, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes. Biochem Pharmacol, 54(8):889–898.
28.
PengL, ZhuangX, LiaoL, HeX, LiJ, ChenX, LuG, MaH, GaoX. 2013. Changes in cell autophagy and apoptosis during age-related left ventricular remodeling in mice and their potential mechanisms. Biochem Biophys Res Commun, 430(2):822–826.
29.
PlanavilaA, IglesiasR, GiraltM, VillarroyaF. 2011. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res, 90(2):276–284.
30.
PolCJ, LieuM, DrosatosK. 2015. PPARs: protectors or opponents of myocardial function?. PPAR Res, 2015:835–985.
31.
PoynterME, DaynesRA. 1998. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem, 273(49):32833–32841.
32.
Puzianowska-KuznickaM, OwczarzM, Wieczorowska-TobisK, NadrowskiP, ChudekJ, SlusarczykP, SkalskaA, JonasM, FranekE, MossakowskaM. 2016. Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing, 13:21.
33.
Romero-CalvoI, OconB, Martinez-MoyaP, SuarezMD, ZarzueloA, Martinez-AugustinO, de MedinaFS. 2010. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem, 401(2):318–320.
34.
RussellLK, MansfieldCM, LehmanJJ, KovacsA, CourtoisM, SaffitzJE, MedeirosDM, ValencikML, McDonaldJA, KellyDP. 2004. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res, 94(4):525–533.
35.
SorianoFX, LiesaM, BachD, ChanDC, PalacinM, ZorzanoA. 2006. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes, 55(6):1783–1791.
36.
SugdenMC, CatonPW, HolnessMJ. 2010. PPAR control: it's SIRTainly as easy as PGC. J Endocrinol, 204(2):93–104.
WangM, ShahAM. 2015. Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries. J Mol Cell Cardiol, 83:101–111.
39.
YanJ, KongW, ZhangQ, BeyerEC, WalcottG, FastVG, AiX. 2013. c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias. Cardiovasc Res, 97(3):589–597.
